260660.KS · 알리코제약

South Korea · RS rating 11 · As of 2026-10-14

Price2,260.00 KRW
1-day change+1.1%
RS rating (overall / 1M / 3M / 12M)11 / 18 / 27 / 16
StageBasing
Composite / Minervini / CANSLIM score19 / 15 / 17
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-12.2%
Sales growth Q/Q-3.0%
Distance from 52-week high+55.2%
Market cap (USD)$26.2M
Open South Korea in the interactive screener